📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa. (2019)

First Author: Lwin SM

Attributed to: Large scale lentiviral vector production funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci.insight.126243

PubMed Identifier: 31167965

Publication URI: http://europepmc.org/abstract/MED/31167965

Type: Journal Article/Review

Volume: 4

Parent Publication: JCI insight

Issue: 11

ISSN: 2379-3708